jump to navigation

Just Bought Bristol-Myers Squibb Company (BMY) as my August purchase September 19, 2019

Posted by deminvest in investment.
Tags: , ,
add a comment

Good price:
Trailing P/E 13.19
Forward P/E 1 8.01

Nice Bioengineering innovation

Honest dividends: 3.29%

Why not?

ExecutedBuy 30 BMY Mkt Day09/18/19 03:59:45 PM EDT3049.8656.95

Just bought 5 shares of Syngenta AG (SYT for NYSE, SVJ.FRA for XETRA)) May 7, 2010

Posted by deminvest in Defensive Stock, investment, MON, Monsanto, SVJ.FR, Syngenta, SYT.
Tags: , , , , , ,
1 comment so far

I ended up choosing  Swiss company  Syngenta AG (SYT) over US Monsanto (Mon)

less controversial, equally agriculture multinational

I just bought 5  SVJ at EUR  187.35 each, spending a total amount of  EUR 936.75.0
I think this agriculture company may be a good defensive stock. After all people eat bread even during economic turmoil times.
I chose Syngenta over Monsanto for several reasons: (more…)

One more free stock for me: 3SBIO (SSRX) happily hit my +40% mark! November 23, 2009

Posted by deminvest in 3SBIO Pharma, China stock, growth stock, investment, investment strategies, my free stock.
Tags: ,
add a comment

3SBio is a Chinese Biotech company.

I bought 110 SSRX shares on Aug 1 2008 for $9.15 each. I spent a total amount of $1001.5

Today I sold 77  SSRX shares @ $13.21. I made a total amount of $ 1017.17.

I am $11 richer and I do own 33  free  SSRX shares, which hopefully one day will make me rich, thanks to my free stocks strategy.

Again I can’t resist bargains: (SSRX) 3SBIO Chinese biotech company had plenty of cash and nice growth August 1, 2008

Posted by deminvest in 3SBIO Pharma, China stock, growth stock, investment, nasdaq, Nasdaq stock, SSRX, stock I own, stocks.
Tags:
6 comments

I studied it last week and buyed it today: this is my zecco order:

08/01/2008 3:56 PM SSRX 110 Buy at $9.15
Market
Executed

I did it beacuse this reserch biotech company already has ok P/E=15, is growing well and has a piplene and plenty of cash to develope new pharmaceuticals.

This move is a bit crazy. Last week I thought I’d buy CMED… but we will see.